Full 2L QBank
Surgery Endocrinology and breast d09e1827

Medical management of insulinoma is

A
Octreotide
B
Streptozotocin
C
Diazoxide
D
Somatomedin
High-Yield Explanation
Medical management is reserved only for patients who are unable or unwilling to undergo surgical treatment or for unresectable metastatic disease. Diazoxide suppresses insulin secretion by direct action on the beta cells and offers reasonably good control of hypoglycaemia in approximately 50%.Ref: Bailey and Love 27e pg: 849

Related Surgery MCQs

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now